avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zic2
|
ENSMUSG00000061524.8 | zinc finger protein of the cerebellum 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Zic2 | mm10_v2_chr14_+_122475397_122475435 | 0.22 | 1.9e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_+_52264323 | 11.13 |
ENSMUST00000039652.4
|
Ins1
|
insulin I |
chr19_+_58728887 | 9.47 |
ENSMUST00000048644.5
|
Pnliprp1
|
pancreatic lipase related protein 1 |
chr7_-_142679533 | 7.65 |
ENSMUST00000162317.1
ENSMUST00000125933.1 ENSMUST00000105931.1 ENSMUST00000105930.1 ENSMUST00000105933.1 ENSMUST00000105932.1 ENSMUST00000000220.2 |
Ins2
|
insulin II |
chr6_-_41314700 | 5.05 |
ENSMUST00000064324.5
|
Try5
|
trypsin 5 |
chr8_-_105933832 | 3.96 |
ENSMUST00000034368.6
|
Ctrl
|
chymotrypsin-like |
chr1_-_37719782 | 2.83 |
ENSMUST00000160589.1
|
2010300C02Rik
|
RIKEN cDNA 2010300C02 gene |
chr4_+_34893772 | 2.51 |
ENSMUST00000029975.3
ENSMUST00000135871.1 ENSMUST00000108130.1 |
Cga
|
glycoprotein hormones, alpha subunit |
chr4_-_141846359 | 2.51 |
ENSMUST00000037059.10
|
Ctrc
|
chymotrypsin C (caldecrin) |
chr4_-_141846277 | 2.42 |
ENSMUST00000105781.1
|
Ctrc
|
chymotrypsin C (caldecrin) |
chr9_+_111019284 | 2.02 |
ENSMUST00000035077.3
|
Ltf
|
lactotransferrin |
chr17_-_56117265 | 1.97 |
ENSMUST00000113072.2
|
Plin5
|
perilipin 5 |
chr4_-_4138817 | 1.89 |
ENSMUST00000133567.1
|
Penk
|
preproenkephalin |
chr4_+_40920047 | 1.79 |
ENSMUST00000030122.4
|
Spink4
|
serine peptidase inhibitor, Kazal type 4 |
chr4_+_44943727 | 1.78 |
ENSMUST00000154177.1
|
Gm12678
|
predicted gene 12678 |
chr14_-_78725089 | 1.62 |
ENSMUST00000074729.5
|
Dgkh
|
diacylglycerol kinase, eta |
chr17_+_25298389 | 1.60 |
ENSMUST00000037453.2
|
Prss34
|
protease, serine, 34 |
chr5_-_122002340 | 1.60 |
ENSMUST00000134326.1
|
Cux2
|
cut-like homeobox 2 |
chr7_+_43781054 | 1.53 |
ENSMUST00000014058.9
|
Klk10
|
kallikrein related-peptidase 10 |
chr7_-_142666816 | 1.52 |
ENSMUST00000105935.1
|
Igf2
|
insulin-like growth factor 2 |
chr3_+_157566868 | 1.47 |
ENSMUST00000041175.6
ENSMUST00000173533.1 |
Ptger3
|
prostaglandin E receptor 3 (subtype EP3) |
chr17_-_56117577 | 1.47 |
ENSMUST00000019808.5
|
Plin5
|
perilipin 5 |
chr12_-_8539545 | 1.45 |
ENSMUST00000095863.3
ENSMUST00000165657.1 |
Slc7a15
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 15 |
chr3_-_92588982 | 1.44 |
ENSMUST00000098888.5
|
Smcp
|
sperm mitochondria-associated cysteine-rich protein |
chr14_-_63509092 | 1.44 |
ENSMUST00000022522.8
|
Tdh
|
L-threonine dehydrogenase |
chr3_+_92316705 | 1.42 |
ENSMUST00000061038.2
|
Sprr2b
|
small proline-rich protein 2B |
chr18_+_36664060 | 1.42 |
ENSMUST00000036765.7
|
Eif4ebp3
|
eukaryotic translation initiation factor 4E binding protein 3 |
chr8_+_109990430 | 1.37 |
ENSMUST00000001720.7
ENSMUST00000143741.1 |
Tat
|
tyrosine aminotransferase |
chr10_+_76253848 | 1.37 |
ENSMUST00000036387.7
|
S100b
|
S100 protein, beta polypeptide, neural |
chrX_+_7919816 | 1.35 |
ENSMUST00000041096.3
|
Pcsk1n
|
proprotein convertase subtilisin/kexin type 1 inhibitor |
chr5_+_100845709 | 1.32 |
ENSMUST00000144623.1
|
Agpat9
|
1-acylglycerol-3-phosphate O-acyltransferase 9 |
chr9_+_123150941 | 1.31 |
ENSMUST00000026890.4
|
Clec3b
|
C-type lectin domain family 3, member b |
chrX_-_7978027 | 1.30 |
ENSMUST00000125418.1
|
Gata1
|
GATA binding protein 1 |
chr7_+_26808880 | 1.27 |
ENSMUST00000040944.7
|
Cyp2g1
|
cytochrome P450, family 2, subfamily g, polypeptide 1 |
chr13_+_13784278 | 1.26 |
ENSMUST00000021734.7
|
Gng4
|
guanine nucleotide binding protein (G protein), gamma 4 |
chr7_-_45615484 | 1.21 |
ENSMUST00000033099.4
|
Fgf21
|
fibroblast growth factor 21 |
chr13_-_62888282 | 1.12 |
ENSMUST00000092888.4
|
Fbp1
|
fructose bisphosphatase 1 |
chr8_-_105471481 | 1.09 |
ENSMUST00000014990.6
|
Tppp3
|
tubulin polymerization-promoting protein family member 3 |
chr11_+_84525669 | 1.06 |
ENSMUST00000126072.1
ENSMUST00000128121.1 |
1500016L03Rik
|
RIKEN cDNA 1500016L03 gene |
chr8_+_80494032 | 1.06 |
ENSMUST00000063359.6
|
Gypa
|
glycophorin A |
chr2_+_92915080 | 1.05 |
ENSMUST00000028648.2
|
Syt13
|
synaptotagmin XIII |
chr12_+_111971545 | 1.03 |
ENSMUST00000079009.5
|
Tdrd9
|
tudor domain containing 9 |
chr13_+_30749226 | 1.02 |
ENSMUST00000021784.2
ENSMUST00000110307.1 |
Irf4
|
interferon regulatory factor 4 |
chr11_-_12026237 | 1.02 |
ENSMUST00000150972.1
|
Grb10
|
growth factor receptor bound protein 10 |
chr7_-_44816586 | 1.01 |
ENSMUST00000047356.8
|
Atf5
|
activating transcription factor 5 |
chr9_+_110344185 | 1.00 |
ENSMUST00000142100.1
|
Scap
|
SREBF chaperone |
chr8_+_104733997 | 0.99 |
ENSMUST00000034346.8
ENSMUST00000164182.2 |
Ces2a
|
carboxylesterase 2A |
chr14_+_70554056 | 0.99 |
ENSMUST00000022691.7
|
Hr
|
hairless |
chr11_+_84525647 | 0.97 |
ENSMUST00000134800.1
|
1500016L03Rik
|
RIKEN cDNA 1500016L03 gene |
chrX_+_136666375 | 0.96 |
ENSMUST00000060904.4
ENSMUST00000113100.1 ENSMUST00000128040.1 |
Tceal3
|
transcription elongation factor A (SII)-like 3 |
chr9_-_111690313 | 0.95 |
ENSMUST00000035083.7
|
Stac
|
src homology three (SH3) and cysteine rich domain |
chr11_-_12026732 | 0.94 |
ENSMUST00000143915.1
|
Grb10
|
growth factor receptor bound protein 10 |
chr7_+_121865070 | 0.93 |
ENSMUST00000033161.5
|
Scnn1b
|
sodium channel, nonvoltage-gated 1 beta |
chr3_+_92215835 | 0.93 |
ENSMUST00000074449.5
ENSMUST00000090871.2 |
Sprr2a1
Sprr2a2
|
small proline-rich protein 2A1 small proline-rich protein 2A2 |
chr7_+_30776394 | 0.92 |
ENSMUST00000041703.7
|
Dmkn
|
dermokine |
chr5_+_135670027 | 0.91 |
ENSMUST00000153500.1
|
Por
|
P450 (cytochrome) oxidoreductase |
chr7_-_46179929 | 0.88 |
ENSMUST00000033123.6
|
Abcc8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
chr5_-_114658414 | 0.87 |
ENSMUST00000112225.1
ENSMUST00000071968.2 |
Trpv4
|
transient receptor potential cation channel, subfamily V, member 4 |
chr5_+_137981512 | 0.85 |
ENSMUST00000035390.5
|
Azgp1
|
alpha-2-glycoprotein 1, zinc |
chr13_-_19307551 | 0.85 |
ENSMUST00000103561.1
|
Tcrg-C2
|
T-cell receptor gamma, constant 2 |
chr9_-_44454757 | 0.82 |
ENSMUST00000047740.2
|
Upk2
|
uroplakin 2 |
chr10_+_75943020 | 0.81 |
ENSMUST00000121151.1
|
Vpreb3
|
pre-B lymphocyte gene 3 |
chr19_+_24673998 | 0.81 |
ENSMUST00000057243.4
|
Tmem252
|
transmembrane protein 252 |
chr7_+_117380937 | 0.81 |
ENSMUST00000032892.5
|
Xylt1
|
xylosyltransferase 1 |
chr6_+_17065129 | 0.80 |
ENSMUST00000115467.4
ENSMUST00000154266.2 ENSMUST00000076654.7 |
Tes
|
testis derived transcript |
chr3_+_92250647 | 0.80 |
ENSMUST00000071805.2
|
Sprr2a2
|
small proline-rich protein 2A2 |
chr14_+_70553687 | 0.78 |
ENSMUST00000161069.1
|
Hr
|
hairless |
chr5_-_120777628 | 0.78 |
ENSMUST00000044833.8
|
Oas3
|
2'-5' oligoadenylate synthetase 3 |
chr7_-_142899985 | 0.78 |
ENSMUST00000000219.3
|
Th
|
tyrosine hydroxylase |
chr17_+_28769307 | 0.77 |
ENSMUST00000004986.6
|
Mapk13
|
mitogen-activated protein kinase 13 |
chrX_+_170009659 | 0.77 |
ENSMUST00000179760.1
|
Gm21887
|
predicted gene, 21887 |
chr12_+_76417598 | 0.77 |
ENSMUST00000063977.7
|
Ppp1r36
|
protein phosphatase 1, regulatory subunit 36 |
chr12_+_104214538 | 0.77 |
ENSMUST00000121337.1
ENSMUST00000167049.1 ENSMUST00000101080.1 |
Serpina3f
|
serine (or cysteine) peptidase inhibitor, clade A, member 3F |
chr12_-_113422730 | 0.76 |
ENSMUST00000177715.1
ENSMUST00000103426.1 |
Ighm
|
immunoglobulin heavy constant mu |
chr6_-_88875035 | 0.76 |
ENSMUST00000145944.1
|
Podxl2
|
podocalyxin-like 2 |
chr15_-_58324161 | 0.71 |
ENSMUST00000022985.1
|
Klhl38
|
kelch-like 38 |
chr5_+_150952607 | 0.70 |
ENSMUST00000078856.6
|
Kl
|
klotho |
chr5_+_139423151 | 0.70 |
ENSMUST00000066211.4
|
Gper1
|
G protein-coupled estrogen receptor 1 |
chr12_-_103958939 | 0.70 |
ENSMUST00000122229.1
|
Serpina1e
|
serine (or cysteine) peptidase inhibitor, clade A, member 1E |
chr18_+_31609512 | 0.69 |
ENSMUST00000164667.1
|
B930094E09Rik
|
RIKEN cDNA B930094E09 gene |
chr12_-_17324703 | 0.69 |
ENSMUST00000020884.9
ENSMUST00000095820.5 ENSMUST00000127185.1 |
Atp6v1c2
|
ATPase, H+ transporting, lysosomal V1 subunit C2 |
chr13_+_19214103 | 0.69 |
ENSMUST00000103558.1
|
Tcrg-C1
|
T cell receptor gamma, constant 1 |
chr4_+_136172367 | 0.68 |
ENSMUST00000061721.5
|
E2f2
|
E2F transcription factor 2 |
chr8_-_31918203 | 0.68 |
ENSMUST00000073884.4
|
Nrg1
|
neuregulin 1 |
chr11_+_7063423 | 0.67 |
ENSMUST00000020706.4
|
Adcy1
|
adenylate cyclase 1 |
chr2_-_32387760 | 0.67 |
ENSMUST00000050785.8
|
Lcn2
|
lipocalin 2 |
chr11_-_100414829 | 0.67 |
ENSMUST00000066489.6
|
Leprel4
|
leprecan-like 4 |
chr6_-_115251839 | 0.66 |
ENSMUST00000032462.6
|
Timp4
|
tissue inhibitor of metalloproteinase 4 |
chr18_-_24709348 | 0.65 |
ENSMUST00000067987.1
|
Gm9955
|
predicted gene 9955 |
chr4_+_47208005 | 0.64 |
ENSMUST00000082303.6
ENSMUST00000102917.4 |
Col15a1
|
collagen, type XV, alpha 1 |
chr16_-_56831878 | 0.64 |
ENSMUST00000135672.1
|
Tmem45a
|
transmembrane protein 45a |
chr15_+_85205949 | 0.63 |
ENSMUST00000057410.7
ENSMUST00000109432.3 |
Fbln1
|
fibulin 1 |
chr19_-_36057340 | 0.63 |
ENSMUST00000164639.1
ENSMUST00000166074.1 ENSMUST00000099505.3 |
Htr7
|
5-hydroxytryptamine (serotonin) receptor 7 |
chr10_+_60106198 | 0.63 |
ENSMUST00000121820.2
|
Spock2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2 |
chr11_-_120731944 | 0.62 |
ENSMUST00000154565.1
ENSMUST00000026148.2 |
Cbr2
|
carbonyl reductase 2 |
chr2_-_180225812 | 0.62 |
ENSMUST00000015791.5
|
Lama5
|
laminin, alpha 5 |
chr2_-_172458596 | 0.61 |
ENSMUST00000099060.1
|
Gcnt7
|
glucosaminyl (N-acetyl) transferase family member 7 |
chr13_-_70841790 | 0.60 |
ENSMUST00000080145.6
ENSMUST00000109694.2 |
Adamts16
|
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 16 |
chr4_+_141368116 | 0.59 |
ENSMUST00000006380.4
|
Fam131c
|
family with sequence similarity 131, member C |
chr17_+_29114142 | 0.57 |
ENSMUST00000141797.1
ENSMUST00000132262.1 ENSMUST00000141239.1 ENSMUST00000138816.1 |
Gm16194
|
predicted gene 16194 |
chr16_+_23058250 | 0.57 |
ENSMUST00000039492.6
ENSMUST00000023589.8 ENSMUST00000089902.6 |
Kng1
|
kininogen 1 |
chr1_-_128359610 | 0.55 |
ENSMUST00000027601.4
|
Mcm6
|
minichromosome maintenance deficient 6 (MIS5 homolog, S. pombe) (S. cerevisiae) |
chrX_-_7967817 | 0.55 |
ENSMUST00000033502.7
|
Gata1
|
GATA binding protein 1 |
chr17_-_35074485 | 0.54 |
ENSMUST00000007259.3
|
Ly6g6d
|
lymphocyte antigen 6 complex, locus G6D |
chrX_+_170009892 | 0.54 |
ENSMUST00000180251.1
|
Gm21887
|
predicted gene, 21887 |
chr4_+_155790439 | 0.53 |
ENSMUST00000165000.1
|
Ankrd65
|
ankyrin repeat domain 65 |
chr1_-_144249134 | 0.53 |
ENSMUST00000172388.1
|
Rgs1
|
regulator of G-protein signaling 1 |
chr10_-_116473418 | 0.53 |
ENSMUST00000087965.4
ENSMUST00000164271.1 |
Kcnmb4
|
potassium large conductance calcium-activated channel, subfamily M, beta member 4 |
chr12_+_84100654 | 0.52 |
ENSMUST00000056822.3
|
Acot6
|
acyl-CoA thioesterase 6 |
chr1_+_88055467 | 0.52 |
ENSMUST00000173325.1
|
Ugt1a10
|
UDP glycosyltransferase 1 family, polypeptide A10 |
chr12_-_104865076 | 0.51 |
ENSMUST00000109937.1
ENSMUST00000109936.1 |
Clmn
|
calmin |
chr15_-_97908261 | 0.51 |
ENSMUST00000023119.8
|
Vdr
|
vitamin D receptor |
chr19_+_6384395 | 0.51 |
ENSMUST00000035269.8
ENSMUST00000113483.1 |
Pygm
|
muscle glycogen phosphorylase |
chr4_-_149909719 | 0.50 |
ENSMUST00000105685.1
|
Spsb1
|
splA/ryanodine receptor domain and SOCS box containing 1 |
chr11_+_96929367 | 0.50 |
ENSMUST00000062172.5
|
Prr15l
|
proline rich 15-like |
chr10_+_40629987 | 0.50 |
ENSMUST00000019977.7
|
Ddo
|
D-aspartate oxidase |
chr12_+_104263117 | 0.50 |
ENSMUST00000109958.2
|
Serpina3i
|
serine (or cysteine) peptidase inhibitor, clade A, member 3I |
chr9_-_65391652 | 0.50 |
ENSMUST00000068307.3
|
Kbtbd13
|
kelch repeat and BTB (POZ) domain containing 13 |
chrY_+_90784738 | 0.50 |
ENSMUST00000179483.1
|
Erdr1
|
erythroid differentiation regulator 1 |
chr7_-_17056669 | 0.49 |
ENSMUST00000037762.4
|
Hif3a
|
hypoxia inducible factor 3, alpha subunit |
chr14_-_120042429 | 0.49 |
ENSMUST00000058213.5
|
Oxgr1
|
oxoglutarate (alpha-ketoglutarate) receptor 1 |
chr9_-_44526397 | 0.49 |
ENSMUST00000062215.7
|
Cxcr5
|
chemokine (C-X-C motif) receptor 5 |
chr1_+_91351016 | 0.49 |
ENSMUST00000027533.8
|
Klhl30
|
kelch-like 30 |
chr10_+_80016901 | 0.48 |
ENSMUST00000105373.1
|
Hmha1
|
histocompatibility (minor) HA-1 |
chr16_-_23029080 | 0.47 |
ENSMUST00000100046.2
|
Kng2
|
kininogen 2 |
chr2_+_157424255 | 0.47 |
ENSMUST00000029175.7
ENSMUST00000092576.4 |
Src
|
Rous sarcoma oncogene |
chr4_-_126163470 | 0.47 |
ENSMUST00000097891.3
|
Sh3d21
|
SH3 domain containing 21 |
chr2_-_24475596 | 0.47 |
ENSMUST00000028355.4
|
Pax8
|
paired box gene 8 |
chr7_-_141117772 | 0.46 |
ENSMUST00000067836.7
|
Ano9
|
anoctamin 9 |
chr12_-_80260091 | 0.46 |
ENSMUST00000167327.1
|
Actn1
|
actinin, alpha 1 |
chr17_-_28486082 | 0.46 |
ENSMUST00000079413.3
|
Fkbp5
|
FK506 binding protein 5 |
chr9_-_119157055 | 0.46 |
ENSMUST00000010795.4
|
Acaa1b
|
acetyl-Coenzyme A acyltransferase 1B |
chr16_-_23029012 | 0.46 |
ENSMUST00000039338.6
|
Kng2
|
kininogen 2 |
chr7_+_141455198 | 0.45 |
ENSMUST00000164016.1
ENSMUST00000064151.6 ENSMUST00000169665.1 |
Pnpla2
|
patatin-like phospholipase domain containing 2 |
chr10_+_127048235 | 0.45 |
ENSMUST00000165764.1
|
Cyp27b1
|
cytochrome P450, family 27, subfamily b, polypeptide 1 |
chr7_+_27119909 | 0.45 |
ENSMUST00000003100.8
|
Cyp2f2
|
cytochrome P450, family 2, subfamily f, polypeptide 2 |
chr7_+_17087934 | 0.44 |
ENSMUST00000152671.1
|
Psg16
|
pregnancy specific glycoprotein 16 |
chr4_-_143299463 | 0.44 |
ENSMUST00000119654.1
|
Pdpn
|
podoplanin |
chr10_+_79879614 | 0.44 |
ENSMUST00000006679.8
|
Prtn3
|
proteinase 3 |
chr16_-_23029062 | 0.44 |
ENSMUST00000115349.2
|
Kng2
|
kininogen 2 |
chr14_-_59365410 | 0.43 |
ENSMUST00000161031.1
ENSMUST00000160425.1 |
Phf11d
|
PHD finger protein 11D |
chr19_-_6235804 | 0.42 |
ENSMUST00000025695.9
|
Ppp2r5b
|
protein phosphatase 2, regulatory subunit B (B56), beta isoform |
chr1_+_88055377 | 0.42 |
ENSMUST00000138182.1
ENSMUST00000113142.3 |
Ugt1a10
|
UDP glycosyltransferase 1 family, polypeptide A10 |
chr11_+_58640394 | 0.42 |
ENSMUST00000075084.4
|
Trim58
|
tripartite motif-containing 58 |
chr3_+_94372794 | 0.42 |
ENSMUST00000029795.3
|
Rorc
|
RAR-related orphan receptor gamma |
chr7_-_28291130 | 0.42 |
ENSMUST00000108316.2
ENSMUST00000056589.6 |
BC089491
|
cDNA sequence BC089491 |
chr3_+_19644452 | 0.41 |
ENSMUST00000029139.7
|
Trim55
|
tripartite motif-containing 55 |
chr1_+_153665666 | 0.41 |
ENSMUST00000111814.1
ENSMUST00000111810.1 |
Rgs8
|
regulator of G-protein signaling 8 |
chr17_-_45572495 | 0.41 |
ENSMUST00000130406.1
|
Hsp90ab1
|
heat shock protein 90 alpha (cytosolic), class B member 1 |
chr2_+_50066429 | 0.41 |
ENSMUST00000112712.3
ENSMUST00000128451.1 ENSMUST00000053208.7 |
Lypd6
|
LY6/PLAUR domain containing 6 |
chr16_+_35154870 | 0.40 |
ENSMUST00000114913.1
|
Adcy5
|
adenylate cyclase 5 |
chr9_+_90163057 | 0.40 |
ENSMUST00000113059.1
ENSMUST00000167122.1 |
Adamts7
|
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 7 |
chr7_+_101818306 | 0.40 |
ENSMUST00000008090.9
|
Phox2a
|
paired-like homeobox 2a |
chr11_+_96929260 | 0.40 |
ENSMUST00000054311.5
ENSMUST00000107636.3 |
Prr15l
|
proline rich 15-like |
chr5_-_148392810 | 0.40 |
ENSMUST00000138257.1
|
Slc7a1
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
chr5_+_137288273 | 0.40 |
ENSMUST00000024099.4
ENSMUST00000085934.3 |
Ache
|
acetylcholinesterase |
chr4_-_111902754 | 0.40 |
ENSMUST00000102719.1
ENSMUST00000102721.1 |
Slc5a9
|
solute carrier family 5 (sodium/glucose cotransporter), member 9 |
chr4_-_111898695 | 0.39 |
ENSMUST00000102720.1
|
Slc5a9
|
solute carrier family 5 (sodium/glucose cotransporter), member 9 |
chr1_-_170589791 | 0.39 |
ENSMUST00000161966.1
ENSMUST00000160456.1 |
Nos1ap
|
nitric oxide synthase 1 (neuronal) adaptor protein |
chr7_-_28547109 | 0.39 |
ENSMUST00000057974.3
|
Nccrp1
|
non-specific cytotoxic cell receptor protein 1 homolog (zebrafish) |
chr15_-_75567176 | 0.38 |
ENSMUST00000156032.1
ENSMUST00000127095.1 |
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr17_+_46297917 | 0.38 |
ENSMUST00000166617.1
ENSMUST00000170271.1 |
Dlk2
|
delta-like 2 homolog (Drosophila) |
chr2_-_33640480 | 0.37 |
ENSMUST00000176067.1
ENSMUST00000041730.4 |
Lmx1b
|
LIM homeobox transcription factor 1 beta |
chr17_+_32685610 | 0.37 |
ENSMUST00000168171.1
|
Cyp4f15
|
cytochrome P450, family 4, subfamily f, polypeptide 15 |
chr5_+_52363925 | 0.37 |
ENSMUST00000101208.4
|
Sod3
|
superoxide dismutase 3, extracellular |
chr14_-_59365465 | 0.37 |
ENSMUST00000095157.4
|
Phf11d
|
PHD finger protein 11D |
chr7_+_45434833 | 0.37 |
ENSMUST00000003964.8
|
Gys1
|
glycogen synthase 1, muscle |
chr2_-_24475097 | 0.37 |
ENSMUST00000149294.1
ENSMUST00000153535.1 |
Pax8
|
paired box gene 8 |
chr5_+_92897981 | 0.36 |
ENSMUST00000113051.2
|
Shroom3
|
shroom family member 3 |
chr2_+_93452796 | 0.35 |
ENSMUST00000099693.2
ENSMUST00000162565.1 ENSMUST00000163052.1 |
Gm10804
|
predicted gene 10804 |
chr7_+_100472985 | 0.35 |
ENSMUST00000032958.7
ENSMUST00000107059.1 |
Ucp3
|
uncoupling protein 3 (mitochondrial, proton carrier) |
chr3_-_88384433 | 0.35 |
ENSMUST00000076048.4
|
Bglap
|
bone gamma carboxyglutamate protein |
chr10_+_127000709 | 0.35 |
ENSMUST00000026500.5
ENSMUST00000142698.1 |
Avil
|
advillin |
chr11_-_106160708 | 0.35 |
ENSMUST00000106875.1
|
Limd2
|
LIM domain containing 2 |
chr7_-_45666292 | 0.35 |
ENSMUST00000069800.4
|
Fut2
|
fucosyltransferase 2 |
chr13_+_52596847 | 0.34 |
ENSMUST00000055087.6
|
Syk
|
spleen tyrosine kinase |
chr10_-_78295394 | 0.34 |
ENSMUST00000105387.1
|
Agpat3
|
1-acylglycerol-3-phosphate O-acyltransferase 3 |
chr10_-_18743691 | 0.34 |
ENSMUST00000019999.5
|
D10Bwg1379e
|
DNA segment, Chr 10, Brigham & Women's Genetics 1379 expressed |
chr10_-_77113676 | 0.34 |
ENSMUST00000072755.4
ENSMUST00000105409.1 |
Col18a1
|
collagen, type XVIII, alpha 1 |
chr5_-_41764493 | 0.34 |
ENSMUST00000060820.6
|
Nkx3-2
|
NK3 homeobox 2 |
chr5_+_139543889 | 0.33 |
ENSMUST00000174792.1
ENSMUST00000031523.8 |
Uncx
|
UNC homeobox |
chr2_-_131063508 | 0.33 |
ENSMUST00000147333.1
|
Adam33
|
a disintegrin and metallopeptidase domain 33 |
chr10_+_80016653 | 0.33 |
ENSMUST00000099501.3
|
Hmha1
|
histocompatibility (minor) HA-1 |
chr11_-_69805617 | 0.33 |
ENSMUST00000051025.4
|
Tmem102
|
transmembrane protein 102 |
chr7_+_82174796 | 0.33 |
ENSMUST00000032874.7
|
Sh3gl3
|
SH3-domain GRB2-like 3 |
chr7_-_19404082 | 0.33 |
ENSMUST00000108458.3
|
Klc3
|
kinesin light chain 3 |
chr11_+_121702591 | 0.33 |
ENSMUST00000125580.1
|
Metrnl
|
meteorin, glial cell differentiation regulator-like |
chr4_+_98546710 | 0.33 |
ENSMUST00000102792.3
|
Inadl
|
InaD-like (Drosophila) |
chr4_+_106622424 | 0.33 |
ENSMUST00000047922.2
|
Ttc22
|
tetratricopeptide repeat domain 22 |
chr12_-_26456423 | 0.33 |
ENSMUST00000020970.7
|
Rsad2
|
radical S-adenosyl methionine domain containing 2 |
chr14_+_51091077 | 0.33 |
ENSMUST00000022428.5
ENSMUST00000171688.1 |
Rnase4
Ang
|
ribonuclease, RNase A family 4 angiogenin, ribonuclease, RNase A family, 5 |
chr9_+_51765325 | 0.32 |
ENSMUST00000065496.5
|
Arhgap20
|
Rho GTPase activating protein 20 |
chr4_-_44072712 | 0.32 |
ENSMUST00000102936.2
|
Gne
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
chr18_-_61786636 | 0.32 |
ENSMUST00000120472.1
|
Afap1l1
|
actin filament associated protein 1-like 1 |
chr8_+_95320440 | 0.32 |
ENSMUST00000162294.1
|
Tepp
|
testis, prostate and placenta expressed |
chr10_+_60106452 | 0.32 |
ENSMUST00000165024.2
|
Spock2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2 |
chr13_+_119836006 | 0.32 |
ENSMUST00000179131.1
|
D13Ertd608e
|
DNA segment, Chr 13, ERATO Doi 608, expressed |
chr15_+_6422240 | 0.32 |
ENSMUST00000163082.1
|
Dab2
|
disabled 2, mitogen-responsive phosphoprotein |
chr4_+_98546919 | 0.31 |
ENSMUST00000030290.7
|
Inadl
|
InaD-like (Drosophila) |
chr19_+_46573362 | 0.31 |
ENSMUST00000026011.6
|
Sfxn2
|
sideroflexin 2 |
chr2_+_26315513 | 0.31 |
ENSMUST00000066936.2
ENSMUST00000078616.5 |
Gpsm1
|
G-protein signalling modulator 1 (AGS3-like, C. elegans) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.6 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) neuron projection maintenance(GO:1990535) |
0.7 | 2.1 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.7 | 3.4 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.6 | 1.9 | GO:0030221 | basophil differentiation(GO:0030221) |
0.4 | 1.3 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.4 | 1.4 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 1.0 | GO:0042231 | interleukin-10 biosynthetic process(GO:0042091) interleukin-13 biosynthetic process(GO:0042231) regulation of interleukin-10 biosynthetic process(GO:0045074) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.3 | 2.0 | GO:1902732 | antifungal humoral response(GO:0019732) positive regulation of chondrocyte proliferation(GO:1902732) |
0.3 | 1.9 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.3 | 0.9 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
0.3 | 0.9 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.3 | 1.1 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.3 | 1.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.3 | 1.9 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 0.8 | GO:0002343 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
0.2 | 1.0 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.2 | 1.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.2 | 0.9 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.2 | 2.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.9 | GO:0090345 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.2 | 1.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 0.6 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.8 | GO:2000612 | regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.2 | 1.4 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.2 | 1.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.2 | 2.5 | GO:0006590 | thyroid hormone generation(GO:0006590) follicle-stimulating hormone secretion(GO:0046884) |
0.2 | 0.5 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 0.8 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.2 | 0.8 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.2 | 0.5 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.2 | 1.7 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.1 | 1.0 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.4 | GO:1903002 | regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) |
0.1 | 0.6 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.1 | 0.4 | GO:1903659 | transforming growth factor beta activation(GO:0036363) regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.1 | 0.4 | GO:0021623 | trochlear nerve development(GO:0021558) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.1 | 0.4 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.1 | 0.4 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.1 | 0.3 | GO:0071226 | cellular response to molecule of fungal origin(GO:0071226) |
0.1 | 0.5 | GO:0042196 | chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
0.1 | 0.3 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 1.9 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.6 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.4 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.2 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.3 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.1 | 0.7 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 0.8 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 1.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 0.7 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.5 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.1 | 0.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.2 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 1.7 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.2 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.1 | 0.9 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.3 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 1.0 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.6 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 1.6 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.3 | GO:0080144 | amino acid homeostasis(GO:0080144) |
0.1 | 1.6 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.3 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.2 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.1 | 0.3 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.1 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.3 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
0.1 | 0.2 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.1 | 1.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.3 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 0.7 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.9 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 9.5 | GO:0015758 | glucose transport(GO:0015758) |
0.1 | 0.2 | GO:0002587 | negative regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002587) |
0.1 | 0.8 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.3 | GO:0035740 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.1 | 0.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.4 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.1 | 0.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 2.1 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 0.2 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.4 | GO:0070317 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.3 | GO:0035026 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) leading edge cell differentiation(GO:0035026) |
0.1 | 0.2 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.1 | 0.2 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.5 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 1.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.4 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.0 | 0.4 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
0.0 | 0.1 | GO:0010920 | negative regulation of inositol phosphate biosynthetic process(GO:0010920) |
0.0 | 0.2 | GO:0060157 | female genitalia morphogenesis(GO:0048807) urinary bladder development(GO:0060157) |
0.0 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 1.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.2 | GO:0030576 | Cajal body organization(GO:0030576) |
0.0 | 0.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.0 | 0.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.0 | 0.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.0 | 0.2 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.0 | 4.8 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.5 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.0 | 0.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.7 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.6 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.2 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.0 | 0.1 | GO:0009816 | defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.0 | 1.9 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 0.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.0 | 0.3 | GO:0099550 | trans-synaptic signalling, modulating synaptic transmission(GO:0099550) |
0.0 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.8 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.0 | 0.0 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.0 | 0.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.1 | GO:0002606 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.0 | 0.3 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.0 | 0.1 | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) |
0.0 | 0.1 | GO:0002355 | detection of tumor cell(GO:0002355) |
0.0 | 0.3 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.9 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.1 | GO:1900114 | dense core granule localization(GO:0032253) positive regulation of histone H3-K9 trimethylation(GO:1900114) dense core granule transport(GO:1901950) regulation of dense core granule transport(GO:1904809) positive regulation of dense core granule transport(GO:1904811) |
0.0 | 0.3 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.0 | 0.6 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.7 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.1 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.0 | 0.9 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.0 | 0.4 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.0 | 0.2 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.0 | 0.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.4 | GO:0042048 | olfactory behavior(GO:0042048) |
0.0 | 0.4 | GO:0015809 | arginine transport(GO:0015809) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.2 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.0 | 1.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.1 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.0 | 0.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.0 | 0.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.3 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.0 | 0.1 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.0 | 0.7 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 0.2 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.2 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.0 | 0.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 0.2 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.7 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.3 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.0 | 0.2 | GO:0040031 | snRNA modification(GO:0040031) |
0.0 | 0.2 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.0 | 0.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.1 | GO:0006868 | glutamine transport(GO:0006868) |
0.0 | 0.3 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.0 | 0.1 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.4 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.0 | 0.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 1.2 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.0 | 0.1 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.0 | 0.5 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.0 | 0.2 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.0 | 0.1 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.0 | 0.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.1 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) follicle-stimulating hormone signaling pathway(GO:0042699) |
0.0 | 0.1 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.0 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.0 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.0 | 0.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.3 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.0 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.3 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.1 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.5 | 2.0 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.4 | 1.5 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.3 | 1.5 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.3 | 7.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 0.9 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 1.3 | GO:0001652 | granular component(GO:0001652) |
0.2 | 0.7 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.2 | 0.6 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 1.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.5 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.1 | 0.5 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.1 | 0.8 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.3 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.1 | 1.0 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.3 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
0.1 | 0.3 | GO:0005940 | septin ring(GO:0005940) |
0.1 | 0.6 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.4 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.1 | 0.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 0.4 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.1 | 0.3 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 0.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 2.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.2 | GO:0014802 | terminal cisterna(GO:0014802) |
0.0 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.6 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.5 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 2.8 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.7 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 11.9 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 1.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.9 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.0 | 0.9 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 1.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 1.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.2 | GO:0044754 | autolysosome(GO:0044754) |
0.0 | 1.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.2 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 1.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.3 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.0 | 5.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.6 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 17.4 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.3 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 1.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.1 | GO:0031673 | H zone(GO:0031673) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 10.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.5 | 1.4 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.4 | 22.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.3 | 3.4 | GO:0035473 | lipase binding(GO:0035473) |
0.3 | 0.9 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.3 | 0.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 1.9 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 0.8 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.2 | 1.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.7 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
0.2 | 0.7 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.2 | 0.9 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.2 | 0.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 0.7 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 1.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 0.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 1.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 0.5 | GO:1902271 | lithocholic acid binding(GO:1902121) D3 vitamins binding(GO:1902271) |
0.2 | 0.6 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.4 | GO:0046911 | metal chelating activity(GO:0046911) |
0.1 | 1.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.6 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 1.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.5 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.1 | 0.4 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.1 | 0.6 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) |
0.1 | 1.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.3 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 1.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.4 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 0.7 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.1 | 0.9 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 1.1 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.1 | 18.3 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.1 | 0.4 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.3 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.9 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.3 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.1 | 0.4 | GO:0002135 | CTP binding(GO:0002135) |
0.1 | 0.5 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.4 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.1 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.2 | GO:0070140 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
0.1 | 0.6 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.4 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 1.8 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.2 | GO:0008443 | 6-phosphofructokinase activity(GO:0003872) phosphofructokinase activity(GO:0008443) |
0.0 | 0.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.0 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.4 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.0 | 0.2 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.0 | 0.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.4 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.0 | 0.7 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 1.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 1.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.3 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 0.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.2 | GO:0002054 | nucleobase binding(GO:0002054) |
0.0 | 0.1 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
0.0 | 3.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.1 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.0 | 0.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.5 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 0.1 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.0 | 0.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.0 | 0.9 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 1.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 1.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 1.6 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.0 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.2 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.0 | 1.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 0.4 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.1 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 1.0 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 0.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.2 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.1 | GO:0008940 | nitrate reductase activity(GO:0008940) |
0.0 | 0.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 1.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 1.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.8 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 0.4 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.2 | GO:0016918 | retinal binding(GO:0016918) retinol binding(GO:0019841) |
0.0 | 0.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 1.2 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.1 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.4 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 5.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 1.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 1.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 2.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 2.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 1.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 2.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 1.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 1.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 1.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 2.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 1.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 2.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 1.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 2.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.7 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 2.4 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 1.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.2 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.0 | 1.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 2.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.7 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.0 | 0.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 3.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 1.2 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 1.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 1.2 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |